SPECIAL REPORT #19     Single-arm studies in oncology         In the April issue of MedNous, Bruno Pagliara, Principal at On-Kòs Pharma, is reporting new data about the use of single-arm studies for the development and registration of new oncology drugs.  Single-arm studies involve one treatment group where all patients […]

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com   SPECIAL REPORT #17     Abnormal Tau Protein Levels in Chronic Traumatic Encephalopathy (CTE)       In November 2016, we had reported the first case of a Mixed Martial Arts cage fighter, 25 years of age, to be publicly identified as having been diagnosed […]

    Btobioinnovation.com      Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #16     Nanobiotix Receives European Market Approval for its Nanoparticle Radioenhancer     Nanobiotix, a Paris based nanomedicine company, founded and incorporated by Laurent Levy in 2003, has obtained a CE mark for the treatment of locally-advanced soft […]

    Btobioinnovation.com        Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com   Special Report #15   Jeff Bezos joins Bill Gates to support Alzheimer’s disease research     On 13 November 2017, Bill Gates announced a plan to donate $50 million of his own money to fund Alzheimer’s disease research. On 3 April […]

Jean-Claude Muller Executive Editor      www.btobioinnovation.com       Transition Energétique: Autopsie d’un Malentendu Chronique       Cette note s’appuie sur une série de lectures à messages contradictoires, de constats parfois alarmants et de réflexions personnelles sur la thématique   Le constat   On dénomme énergies renouvelables les énergies éoliennes, solaires, hydrauliques, géothermiques, marines et […]